Abstracts tagged "Sjogren’s syndrome and proteomics"

Abstract Number: 527 • 2014 ACR/ARHP Annual Meeting
Salivary Expression of S100A7/Psoriasin and Oral Damage in Primary Sjögren’s Syndrome and Overlapping Disorders
Francesca Sernissi¹, Chiara Baldini¹, Daniela Martini¹, Leonardo Lorenzini¹, Laura Bazzichi¹, Antonietta Raffaella Maria Sabbatini¹, Giada Marchi¹, Camillo Giacomelli¹, Marta Mosca² and Stefano Bombardieri², ¹University of Pisa, Rheumatology Unit, Pisa, Italy, ²Rheumatology Unit, University of Pisa, Pisa, Italy
Background/Purpose: S100A7/psoriasin, a 11.4kDa protein belonging to the S100A family of Ca2+-binding proteins, is known to exhibit an antimicrobial activity at skin level, but has…
Abstract Number: 1900 • 2013 ACR/ARHP Annual Meeting
Mass Spectrometry-Based Salivary Proteomics For The Discovery Of Novel Diagnostic Biomarkers For Primary Sjögren’s Syndrome and Its Clinical Subsets
Camillo Giacomelli¹, Chiara Baldini¹, Francesca Sernissi¹, Daniela Martini¹, Pasquale Pepe², Nicoletta Luciano¹, Francesco Ferro¹, Chiara Tani¹, Marta Mosca³ and Stefano Bombardieri¹, ¹University of Pisa, Rheumatology Unit, Pisa, Italy, ²Institute of Clinical Physiology, National Research Council, Pisa, Italy, ³Rheumatology Unit, University of Pisa, Pisa, Italy
Background/Purpose: Nowadays, the advances of novel proteomic technologies are encouraging research projects for generating reliable diagnostic biomarkers for primary Sjögren’s syndrome (pSS) to be used…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].